Safety and efficacy of SHR-1316 combined with chemotherapy and sequential chest radiotherapy as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC): The results from a phase II single-arm trial.

已取消 10 由 dwq 发布于 2024/8/22 10:06:56

DOI:10.1200/jco.2022.40.16_suppl.8563
作者：Dawei Chen, B. Zou, Xiangjiao Meng, Wei Huang, Q. Shao, Xiao-yong Tang, Jun Guo, Xudong Hu, Yan Zhang, Lei Fu, Yuan Jiajia, Jinming Yu, Linlin Wang
文献类型：期刊论文
补充材料：只需要正文

American Society of Clinical Oncology (ASCO)

Abstract：8563 Background: Impower133 and CASPIAN studies showed that PD-L1 antibody combined with first-line chemotherapy could prolong the overall survival. Previous studies have shown that radiothe

应助信息

2024-08-22

Book学术机器人

2024/8/22 10:06:56 未找到该文献，机器人已退出，请等待人工下载

2024/8/22 10:06:56 Book学术AI机器人收到请求，开始寻找文献

2024/8/22 10:06:56 已向机器人发送请求

2024-08-22

dwq 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierPolydopamine/tannic acid/chitosan/poloxamer 407/188 thermosensitive hydrogel for antibacterial and wound healing